Definition of Yttrium Y 90 ibritumomab tiuxetan

Reviewed on 6/3/2021

Yttrium Y 90 ibritumomab tiuxetan: An anticancer therapy that is a combination of the radioisotope yttrium-90 and a monoclonal antibody to produce substances that locate and bind to cancer cells. Also called IDEC-Y2B8 monoclonal antibody.


Skin Cancer Symptoms, Types, Images See Slideshow

Health Solutions From Our Sponsors